Permeability of retinal pigment epithelium: Effects of permeant molecular weight and lipophilicity

Investigative Ophthalmology and Visual Science

Volumn 46, Issue 2, 2005, Pages 641-646

  Pitkänen, Leena ^a   Ranta, Veli Pekka ^a   Moilanen, Hanna ^a   Urtti, Arto ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETAXOLOL; CARBOXYFLUORESCEIN; DEXTRAN; FLUORESCEIN ISOTHIOCYANATE; METOPROLOL; NADOLOL; PINDOLOL; TIMOLOL;

ANIMAL TISSUE; ARTICLE; CHOROID; CONTROLLED STUDY; DIFFUSION CHAMBER; DRUG PENETRATION; ELECTRIC RESISTANCE; FLUOROMETRY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LIPOPHILICITY; MOLECULAR WEIGHT; NONHUMAN; PIGMENT EPITHELIUM; POTENTIAL DIFFERENCE; PRIORITY JOURNAL; SOLUTE; STATISTICAL ANALYSIS; SWINE;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; CATTLE; CHOROID; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DEXTRANS; DIFFUSION; DIFFUSION CHAMBERS, CULTURE; DRUG DELIVERY SYSTEMS; ELECTRIC CONDUCTIVITY; ELECTRIC IMPEDANCE; FLUORESCEIN-5-ISOTHIOCYANATE; FLUORESCEINS; FLUOROPHOTOMETRY; MOLECULAR WEIGHT; PERMEABILITY; PIGMENT EPITHELIUM OF EYE; SCLERA;

EID: 13944264268     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.04-1051     Document Type: Article

References (37)

1. Olsen TW, Edelhauser HF, Lim JI, Geroski DH. Human scleral permeability: effects of age, cryotherapy, transscleral diode laser, and surgical thinning. Invest Ophthalmol Vis Sci. 1995;36:1893-1903.
2. Geroski DH, Edelhauser HF. Drug delivery for posterior segment eye disease. Invest Ophthalmol Vis Sci. 2000;41:96l-964.
3. Maurice DM, Mishima S. Ocular pharmacokinetics. In: Sears ML, ed. Pharmacology of the Eye. Berlin: Springler-Verlag; 1984:19-116.
4. Cunha-Vaz JG. The blood-retinal barrier system. Basic concepts and clinical evaluation. Exp Eye Res. 2004;78:715-721.
5. Kato A, Kimura H, Okabe K, Okabe J, Kunou N, Ogura Y. Feasibility of drug delivery to the posterior pole of the rabbit eye with an episcleral implant. Invest Ophthalmol Vis Sci. 2004;45:238-244.
6. Ahmed I, Patton TF. Disposition of timolol and inulin in the rabbit eye following corneal versus non-corneal absorption. Int J Pharm. 1987;38:9-21.
7. Ambati J, Canakis CS, Miller JW, et al. Diffusion of high molecular weight compounds through sclera. Invest Ophthalmol Vis Sci. 2000;41:1181-1185.
8. Prausnitz MR, Noonan JS. Permeability of cornea, sclera, and conjunctiva: a literature analysis for drug delivery to the eye. J Pharm Sci. 1998;87:1479-1488.
9. Moore DJ, Clover GM. The effect of age on the macromolecular permeability of human Bruch's membrane. Invest Ophthalmol Vis Sci. 2001;42:2970-2975.
10. Peyman GA, Bok D. Peroxidase diffusion in the normal and laser-coagulated primate retina. Invest Ophthalmol. 1972;11:35-45.
11. Marmor MF, Negi A, Maurice DM. Kinetics of macromolecules injected into the subretinal space. Exp Eye Res. 1985;40:687-696.
12. Zinn KM, Benjamin-Henkind J. Retinal pigment epithelium. In: Tasman W, ed. Duane's Foundations of Clinical Ophthalmology. Vol. 1. Philadelphia: Lippincott-Raven; 1995:Chap 21:1-20.
13. Toris CB, Pederson JE. Experimental retinal detachment. VII. Intravenous horseradish peroxidase diffusion across the blood-retinal barrier. Arch Ophthalmol. 1984;102:752-756.
14. Kennedy BG, Mangini NJ. P-glycoprotein expression in human retinal pigment epithelium. Mol Vision. 2002;8:422-430.
15. Araie M, Maurice DM. The loss of fluorescein, fluorescein glucuronide and fluorescein isothiocyanate dextran from the vitreous by the anterior and retinal pathways. Exp Eye Res. 1991;52:27-39.
16. Schoenwald RD, Huang HS. Corneal penetration behavior of beta-blocking agents I: Physicochemical factors. J Pharm Sci. 1983;72: 1266-1272.
17. Wang W, Sasaki H, Chien DS, Lee VH. Lipophilicity influence on conjunctival drug penetration in the pigmented rabbit: a comparison with corneal penetration. Curr Eye Res. 1991;10:571-579.
18. Miller SS, Edelman JL. Active ion transport pathways in the bovine retinal pigment epithelium. J Physiol. 1990;424:283-300.
19. Ranta VP, Toropainen E, Talvitie A, Auriola S, Urtti A. Simultaneous determination of eight beta-blockers by gradient high-performance liquid chromatography with combined ultraviolet and fluorescence detection in corneal permeability studies in vitro. J Chromatogr B. 2002;772:81-87.
20. Gehlbach P, Demetriades AM, Yamamoto S, et al. Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier. Hum Gene Ther. 2003;14:129-141.
21. Cunha-Vaz JG, Maurice DM. The active transport of fluorescein by retinal vessels and the retina. J Physiol. 1967;191:467-486.
22. Kimura M, Araie M, Koyano S. Movement of carboxyfluorescein across retinal pigment epithelium-choroid. Exp Eye Res. 1996;63: 51-56.
23. Steuer H, Jaworski A, Stoll D, Schlosshauer B. In vitro model of the outer blood-retina barrier. Brain Res Protocols. 2004;13:26-36.
24. Edelman JL, Miller SS. Epinephrine stimulates fluid absorption across bovine retinal pigment epithelium. Invest Ophthalmol Vis Sci. 1991;32:3033-3040.
25. Arndt CF, Sari A, Ferre M, et al. Electrophysiological effects of corticosteroids on the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2001;42:472-475.
26. Tsuboi S, Pederson J. Permeability of the isolated dog retinal pigment epithelium to carboxyfluorescein. Invest Ophthalmol Vis Sci. 1986;27:1767-1770.
27. Araie M, Kimura M. Intraocular irrigating solutions and barrier function of retinal pigment epithelium. Br J Ophthalmol. 1997; 81:150-153.
28. Ruponen M, Honkakoski P, Tammi M, Urtti A. Cell-surface glycosaminoglycans inhibit cation-mediated gene transfer. J Gene Med. 2004;6:405-414.
29. Kim JW, Lindsey JD, Wang N, Weinreb RN. Increased human scleral permeability with prostaglandin exposure. Invest Ophthalmol Vis Sci. 2001;42:1514-1521.
30. Maurice DM, Polgar J. Diffusion across the sclera. Exp Eye Res. 1977;25:577-582.
31. Rudnick DE, Noonan JS, Geroski DH, Prausnitz MR, Edelhauser HF. The effect of intraocular pressure on human and rabbit scleral permeability. Invest Ophthalmol Vis Sci. 1999;40:3054-3058.
32. Olsen TW, Aaberg SY, Geroski DH, Edelhauser HF. Human sclera: thickness and surface area. Am J Ophthalmol. 1998;125:237-241.
33. Hamilton KO, Yazdanian MA, Audus KL. Modulation of P-glycoprotein activity in Calu-3 cells using steroids and β-ligands. Int J Pharm. 2001;228:171-179.
34. Crank J, Park GS. Methods of measurement. In: Crank J, Park GS, eds. Diffusion in Polymers. London: Academic Press; 1968:1-37.
35. Salminen L, Urtti A. Disposition of ophthalmic timolol in treated and untreated rabbit eyes: a multiple and single dose study. Exp Eye Res. 1984;38:203-206.
36. Tsuchiya M, Hayasaka S, Mizuno K. Affinity of ocular acid-insoluble melanin for drugs in vitro. Invest Ophthalmol Vis Sci. 1987;28: 822-825.
37. Buszman E, Rozanska R. Interaction of quinidine, disopyramide and metoprolol with melanin in vitro in relation to drug-induced ocular toxicity. Pharmazie. 2003;58:507-511.